For example, if the expression of the HLA-I/HLA-II molecules is suppressed or impaired, epitopes of the peptides/HLA-II molecules introduced to the tumor may not be adequately presented to CD8+ and CD4+ T cells, the function of which might be impaired as well. This evidence concerns the gene CD8A and neoplasm.